Browsing by Author "2db4f697-938f-4456-b9d5-85058f67e93c"

Now showing items 1-2 of 2

    • Direct-acting antivirals and Hepatocellular Carcinoma: No evidence of higher wait-list progression or ... 
      Piñero, Federico; Boin, Ilka; Chagas, Aline; Quiñonez, Emilio; Marciano, Sebastián; Vilatobá, Mario; Santos, Luisa; Anders, Margarita; Hoyos Duque, Sergio; Soares Lima, Agnaldo; Menéndez, Josemaría; Padilla, Martín; Poniachik Teller, Jaime; Zapata, Rodrigo; Maraschio, Martín; Chong Menéndez, Ricardo; Muñoz, Linda; Arufe, Diego; Figueroa, Rodrigo; Mendizábal, Manuel; Hurtado Gómez, Sahara; Stucchi, Raquel; Maccali, Claudia; Vergara Sandoval, Rodrigo; Bermudez, Carla; McCormack, Lucas; Varón, Adriana; Gadano, Adrián; Mattera, Juan; Rubinstein, Fernando; Carrilho, Flair; Silva, Marcelo (Wiley, 2020)
      The association between direct-acting antivirals (DAAs) and hepatocellular carcinoma (HCC) wait-list progression or its recurrence following liver transplantation (LT) remains uncertain. We evaluated the impact of DAAs on ...
    • Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment ... 
      Arab, Juan Pablo; Dirchwolf, Melisa; Álvarez da Silva, Mario Reis; Barrera, Francisco; Benítez, Carlos; Castellanos Fernández, Marlene; Castro Narro, Graciela; Chávez Tapia, Norberto; Chiodi, Daniela; Cotrim, Helma; Cusi, Kenneth; Marques Souza de Oliveira, Claudia Pinto; Díaz, Javier; Fassio, Eduardo; Gerona, Solange; Girala, Marcos; Hernández, Nelia; Marciano, Sebastián; Masson, Walter; Méndez Sánchez, Nahum; Leite, Nathalie; Lozano, Adelina; Padilla, Martín; Panduro, Arturo; Paraná, Raymundo; Parise, Edison; Pérez, Marlene; Poniachik, Jaime; Restrepo, Juan Carlos; Ruf, Andrés; Silva, Marcelo G.; Tagle, Martín; Tapias, Mónica; Torres, Kenia; Vilar Gómez, Eduardo; Costa Gil, José Eduardo; Gadano, Adrián; Arrese, Marco (Elsevier, 2020)
      Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence ...